Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 2000

Study Completion Date

August 31, 2007

Conditions

Breast Cancer

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

therapeutic allogeneic lymphocytes

DRUG

cyclophosphamide

DRUG

cyclosporine

DRUG

fludarabine phosphate

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (2)

NCI - Center for Cancer Research, Bethesda

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00020176 - Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | Biotech Hunter | Biotech Hunter